Apellis Clinical Trial Recruiting


We have learned about a clinical research trial for a new investigational treatment option for subjects with primary Warm Autoimmune Hemolytic Anemia (wAIHA) or Cold Agglutinin Disease (CAD).

Apellis Pharmaceuticals is sponsoring this trial to evaluate the effectiveness, safety and tolerability of an investigational medication for participants with wAIHA or CAD [NCT03226678].

For more information on this clinical trial and to enter your contact information for follow-up, please visit the trial website: https://aihaclinicaltrial.com

You may also contact Apellis directly at Click here to send an email or Betty Usdan at Click here to send an email